Global Overactive Bladder Therapeutics Market 2014-2018

2014-11-05
Price :
Published : Nov-2014
No. of Pages : 91

Overactive bladder is a urological condition associated with urination problems. The condition is characterized by bladder storage symptoms such as urgency, change in frequency of urination, nocturia, or urinary incontinence. It is also known as overactive bladder syndrome. Although it is not a life-threatening condition, it is often stigmatized and debilitating. Some of the important symptoms of overactive bladder are urinary urgency and incontinence. The pathophysiology of overactive bladder is not characterized completely. The symptoms of overactive bladder can last for a lifetime or it can relapse and remit. The problem can be resolved through treatment. Overactive bladder can affect a person irrespective of the gender. The reason is the abnormal contraction of the urinary detrusor muscle of the bladder. In addition, overactive bladder can be related to neurological diseases such as Parkinson’s disease and multiple sclerosis.

TechNavio’s analysts forecast the Global Overactive Bladder Therapeutics market to grow at a CAGR of 1.14 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Overactive Bladder Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of overactive bladder, which include:

  • Anti-muscarinic Agent
  • Beta-3-Adrenergic Receptor Agonist

TechNavio’s report, Global Overactive Bladder Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Overactive Bladder Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Actavis
  • Allergan
  • Astellas Pharma
  • Pfizer

Other Prominent Vendors

  • Addex Therapeutics
  • AltheRx Pharmaceuticals
  • American Oriental Bioengineering
  • Antares Pharma
  • Apogepha Arzneimittel
  • Auxilium Pharmaceuticals
  • Bayer
  • elbion
  • FemmePharma
  • Ferring Pharmaceuticals
  • GlaxoSmithKline
  • Hisamitsu Pharmaceutical
  • Hydra Biosciences
  • Ion Channel Innovations
  • Ipsen
  • Janssen
  • Kissei Pharma
  • Kwang Dong Pharmaceutical
  • KYORIN Pharma
  • Laboratorios SALVAT
  • LG Life Sciences
  • Lipella Pharmaceuticals
  • Merck
  • Motif BioSciences
  • Mylan
  • Novartis
  • Ono Pharmaceuticals
  • Ranbaxy Laboratories
  • Recordati
  • Sanofi
  • Sunovion
  • Takeda Pharmaceutical
  • TARIS BioMedical
  • Teva Pharmaceutical
  • TheraVida
  • Toray Industries
  • Urigen Pharmaceuticals

Market Driver

  • Rise in Geriatric Population
  • For a full, detailed list, view our report

Market Challenge

  • Difficulty in Disease Diagnosis
  • For a full, detailed list, view our report

Market Trend

  • Increase in Awareness
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela Summary Venezuela ranked 187 out of 190 countries in ease of doing business. In July 2017, rating firm Standard & Poor's downgraded Venezuela's economy to CCC with a negative outlook. Moody's also downgraded its rating to Caa3 with a negative outlook, while Fitch rated it at CCC with a negative outlook. Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. The value of the market was US$12.6 Billion in 2015, having increased from US$5.7 Billion in 2009, at a Compound Annual Growth Rate (CAGR) of 14.1%. Drug prices in Venezuela are ......
$1995

Hemorrhage Global Clinical Trials Review, H2, 2017

Hemorrhage Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhage Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Hepatitis C Global Clinical Trials Review, H2, 2017

Hepatitis C Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis C Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis C clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis C. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017

Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2017" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - ......
$2500

Hemorrhagic Fever Global Clinical Trials Review, H2, 2017

Hemorrhagic Fever Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhagic Fever Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhagic Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhagic Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Hepatitis D Global Clinical Trials Review, H2, 2017

Hepatitis D Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis D Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis D clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis D. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017

Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2017" provides an overview of Heterozygous familial hypercholesterolemia (heFH) clinical trials scenario. This report provides top line data relating to the clinical trials on Heterozygous familial hypercholesterolemia (heFH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing......
$2500

Hemorrhagic Shock Global Clinical Trials Review, H2, 2017

Hemorrhagic Shock Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhagic Shock Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhagic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhagic Shock. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Hepatitis E Global Clinical Trials Review, H2, 2017

Hepatitis E Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatitis E Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis E clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis E. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Hemorrhoids Global Clinical Trials Review, H2, 2017

Hemorrhoids Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemorrhoids Global Clinical Trials Review, H2, 2017" provides an overview of Hemorrhoids clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhoids. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500